- Country: Ukraine
- Summary: Amlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets of 30 Mg; Ambroxol, Solution for Injection/Infusion 7, ...
- UAT Ref No: 119662197
- Deadline: 27 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 679675.9
- Notice Type: Tender
- Document Ref. No.: UA-2025-05-22-013898-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Amlodipine/Valsartan/hydrochlorothiazide 5 mg/160 mg/12.5 mg of tablets; Aminocaproic acid, infusion solution, 50 mg/ml, 100 ml; Ambroxol tablets of 30 mg; Ambroxol, solution for injection/infusion 7.5 mg/ml, 2 ml; Ascorbic acid solution for injection, 100 mg/ml of 2 ml; Potassium asparaginate/magnesiumasparaginate solution for injection of 5 ml; Barbiturates in combination with drugs of other groups of capsule (ethyl ether 10 mg, menthol solution in the mentilic ether of acid isovalerian - 46 mg, phenobarbital - 9.8 mg); Brilliant green solution for external use, alcohol 1 %, 20 ml;Bromhexine tablets of 8 mg; Barbiturates in combination with drugs of other groups (valocordin), oral drops, 50 ml; Gelatin preparation solution for infusions of 500 ml; Doxylamine tablets are covered with a shell of 15 mg; Gecoton solution for 400 ml infusions; Sodium heparin, gel, 1000 IU/g, 40 g; Arginineglutamate solution for injection 400 mg/ml, 5 ml; Arginine glutamate, tablets, 0.75 g; Glucose solution for infusions 5 % 200 ml (glass); Glucose solution for infusion 10 % 200 ml; Silymarin, tablets covered with a shell, 22.5 mg; Acetylcysteine powder/pellets 600 mg; Decametoxin, solution, 0.2mg/ml, 200 ml; Deketoprofen solution for injection of 25 mg/ ml of 2 ml; Dexamethasone drops of ocular 1 mg/ml of 10 ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml; Etamzilate solution for injection, 125 mg/ml of 2 ml; Ceftazidim, injection powder 1.0 gr; Calcium chloride solution for injection, 100M ...
Purchase type: goods
DK 021: 2015: 33600000-6: Pharmaceutical products
Amlodipine/Valsartan/Hydrochlortiazide 5 mg/160 mg/12.5 mg Tablets, aminocaproic acid, solution for infusions, 50 mg/ml. Ambroxol, solution for injection/infusion 7.5 mg/ml, 2ml, ascorbicAcid solution for injection, 100 mg/ml of 2 ml, potassium asparaginate/magnesium asparaginate solution for injection of 5 ml, barbiturates in combination with drugs of other capsule groups (ethyl ether 10 mg, ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAmlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets of 30 Mg; Ambroxol, Solution for Injection/Infusion 7, ... - Ukraine Tender
The MUNICIPAL NON -COMMERCIAL ENTERPRISE "CHERKASY REGIONAL TUBERCULOSIS DISPENSARY OF CHERKASY REGIONAL COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Amlodipine/Valsartan/Hydrochlorothiazide 5 Mg/160 Mg/12.5 Mg of Tablets; Aminocaproic Acid, Infusion Solution, 50 Mg/Ml, 100 Ml; Ambroxol Tablets of 30 Mg; Ambroxol, Solution for Injection/Infusion 7, .... This tender is published on UkraineTenders under UAT Ref No: 119662197 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-27.
The estimated tender value is UAH 679675.9, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
